ROCHESTER, N.Y. — Bausch & Lomb and Alcon Laboratories, Inc., today issued the following joint statement:
Bausch & Lomb Incorporated and Alcon Laboratories, Inc., have settled the lawsuit recently filed by Bausch & Lomb concerning Alcon’s promotional claims about Bausch & Lomb’s ReNu MultiPlus® multi-purpose disinfecting solution.
The suit centered on Alcon’s use of a color-coded chart showing differences in superficial punctate transient corneal staining profiles observed in Dr. Gary Andrasko’s research. To address Bausch & Lomb’s concern over the red-yellow color scheme of Dr Andrasko’s corneal staining grid, Alcon has agreed to change the red-yellow color scheme used in its promotional materials.
The use of the color scheme in Alcon’s materials was not intended to communicate that the lens-solution combinations designated red or yellow meant danger or caution, and was not meant to suggest an increased risk of corneal infection. There are several factors that may contribute to the risk of corneal infection, and the parties acknowledge that there is no clinical evidence that the differences in corneal staining observed by Dr. Andrasko increase the risk of infection.
In light of Alcon’s and Bausch & Lomb’s agreements, the lawsuit has been dismissed with prejudice, without any payment of damages from either party.
About Bausch & Lomb
Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y. Bausch & Lomb’s 2006 revenues were more than $2.2 billion; it employs more than 13,000 people worldwide and its products are available in more than 100 countries. More information can be found at www.bausch.com.
ReNu MultiPlus is a trademark of Bausch & Lomb Incorporated.